DK135389A - Osmotisk indretning til administration af en terapeutisk effektiv maengde laegemiddel - Google Patents

Osmotisk indretning til administration af en terapeutisk effektiv maengde laegemiddel

Info

Publication number
DK135389A
DK135389A DK135389A DK135389A DK135389A DK 135389 A DK135389 A DK 135389A DK 135389 A DK135389 A DK 135389A DK 135389 A DK135389 A DK 135389A DK 135389 A DK135389 A DK 135389A
Authority
DK
Denmark
Prior art keywords
administrating
medicine
therapeutically effective
effective quantity
osmotic device
Prior art date
Application number
DK135389A
Other languages
English (en)
Other versions
DK175637B1 (da
DK135389D0 (da
Inventor
Joseph C Deters
Patrick S-L Wong
Brian L Barclay
Felix Theeuwes
David R Swanson
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of DK135389D0 publication Critical patent/DK135389D0/da
Publication of DK135389A publication Critical patent/DK135389A/da
Application granted granted Critical
Publication of DK175637B1 publication Critical patent/DK175637B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
DK198901353A 1988-03-21 1989-03-20 Osmotisk indretning til administration af en terapeutisk effektiv mængde lægemiddel DK175637B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/173,524 US4837111A (en) 1988-03-21 1988-03-21 Dosage form for dispensing drug for human therapy
US17352488 1988-03-21

Publications (3)

Publication Number Publication Date
DK135389D0 DK135389D0 (da) 1989-03-20
DK135389A true DK135389A (da) 1989-09-22
DK175637B1 DK175637B1 (da) 2005-01-03

Family

ID=22632422

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198901353A DK175637B1 (da) 1988-03-21 1989-03-20 Osmotisk indretning til administration af en terapeutisk effektiv mængde lægemiddel

Country Status (11)

Country Link
US (1) US4837111A (da)
EP (1) EP0334465B1 (da)
JP (1) JP2729072B2 (da)
AT (1) ATE96308T1 (da)
CA (1) CA1315687C (da)
DE (1) DE68910159T2 (da)
DK (1) DK175637B1 (da)
ES (1) ES2045400T3 (da)
IE (1) IE62131B1 (da)
MX (1) MX9203554A (da)
PT (1) PT90049B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023076A (en) * 1987-02-27 1991-06-11 Alza Corporation Lamina comprising carboxyvinyl polymer
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5002540A (en) * 1989-05-22 1991-03-26 Warren Kirschbaum Intravaginal device and method for delivering a medicament
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
JPH0794379B2 (ja) * 1990-08-07 1995-10-11 ファイザー・インコーポレーテッド 放出製剤における界面重合膜の使用方法
GB9101502D0 (en) * 1991-01-23 1991-03-06 Controlled Therapeutics Sct Controlled release compositions
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US5226902A (en) * 1991-07-30 1993-07-13 University Of Utah Pulsatile drug delivery device using stimuli sensitive hydrogel
US5266332A (en) * 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
US5254349A (en) * 1991-12-06 1993-10-19 Alza Corporation Process for lessening irritation caused by drug
US5200195A (en) * 1991-12-06 1993-04-06 Alza Corporation Process for improving dosage form delivery kinetics
US5531734A (en) * 1995-01-13 1996-07-02 Abbott Laboratories Method of altering composition of nutritional product during enteral tube feeding
US5945125A (en) * 1995-02-28 1999-08-31 Temple University Controlled release tablet
US5713852A (en) * 1995-06-07 1998-02-03 Alza Corporation Oral dosage and method for treating painful conditions of the oral cavity
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
US6080132A (en) * 1998-02-27 2000-06-27 Abbott Laboratories Apparatus for altering characteristics of a fluid
US6309373B1 (en) 1998-08-12 2001-10-30 Abbott Laboratories Apparatus for altering the characteristics of a fluid
US6264695B1 (en) * 1999-09-30 2001-07-24 Replication Medical, Inc. Spinal nucleus implant
DE60026357T2 (de) * 1999-11-12 2006-10-19 MacroMed, Inc., Sandy An- und abschwellende polymermischungen
US6537584B1 (en) 1999-11-12 2003-03-25 Macromed, Inc. Polymer blends that swell in an acidic environment and deswell in a basic environment
EP1239839A2 (en) 1999-12-23 2002-09-18 Pfizer Products Inc. Hydrogel-driven layered drug dosage form comprising sertraline
US6464688B1 (en) 2000-02-15 2002-10-15 Microsolutions, Inc. Osmotic pump delivery system with flexible drug compartment
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
JP2004537566A (ja) * 2001-08-01 2004-12-16 ブリストル−マイヤーズ　スクイブ　カンパニー 味マスキング組成物
KR100453288B1 (ko) * 2002-03-12 2004-10-21 한국화학연구원 약물의 제어 방출을 위한 스퀴즈-유형의 삼투성 약물 전달장치
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
EP1824491A1 (en) * 2004-11-22 2007-08-29 Ranbaxy Laboratories Limited Monocompartment osmotic-controlled delivery system of doxazosin
WO2008021891A2 (en) * 2006-08-08 2008-02-21 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
CN101439026B (zh) * 2007-11-23 2011-04-06 北京红林制药有限公司 含有多沙唑嗪或其盐的控释制剂及其制备方法
CN109589491B (zh) * 2019-01-29 2024-01-09 上海安翰医疗技术有限公司 自动给药装置
WO2025235973A1 (en) * 2024-05-09 2025-11-13 Deep Brain Bci Corporation Implantable medical devices for delivering therapeutics and brain-computer interface systems

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4320759A (en) * 1980-04-28 1982-03-23 Alza Corporation Dispenser with diffuser
US4309996A (en) * 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4532135A (en) * 1981-02-09 1985-07-30 Edwards K David G Renoprotective treatments employing vasodilator compounds
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4765989A (en) * 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
US4760057A (en) * 1983-06-23 1988-07-26 Merck & Co., Inc. (Acyloxyalkoxy)carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs
US4609374A (en) * 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
US4842867A (en) * 1986-05-09 1989-06-27 Alza Corporation Pulsed drug delivery of doxylamine
EP0253554A3 (en) * 1986-07-15 1988-07-20 Pfizer Inc. Controlled release drug-containing fibers
US4758569A (en) * 1987-08-26 1988-07-19 Pfizer Inc. Doxazosin as an anti-atherosclerosis agent

Also Published As

Publication number Publication date
US4837111A (en) 1989-06-06
DK175637B1 (da) 2005-01-03
DK135389D0 (da) 1989-03-20
CA1315687C (en) 1993-04-06
EP0334465B1 (en) 1993-10-27
MX9203554A (es) 1992-09-01
JPH01242528A (ja) 1989-09-27
HK1003980A1 (en) 1998-11-13
DE68910159T2 (de) 1994-02-17
IE890142L (en) 1989-09-21
ES2045400T3 (es) 1994-01-16
JP2729072B2 (ja) 1998-03-18
ATE96308T1 (de) 1993-11-15
IE62131B1 (en) 1994-12-14
EP0334465A1 (en) 1989-09-27
PT90049B (pt) 1995-03-01
DE68910159D1 (de) 1993-12-02
PT90049A (pt) 1989-11-10

Similar Documents

Publication Publication Date Title
DK135389A (da) Osmotisk indretning til administration af en terapeutisk effektiv maengde laegemiddel
NO934487L (no) Doseringsanordning med forsinket medikamentavgivelse
DK583789D0 (da) System til transmucosal indgivelse af den aktive bestanddel af et laegemiddel
DK156375C (da) Praeparater til oral administration til droevtyggere med langvarig medikamentafgivelse
FI924376A0 (fi) Aktivitetsreglerande, elektriskt fungerande anordning foer administrering av laekemedel.
DK367687D0 (da) Farmaceutisk praeparat til oral indgift med reguleret afgivelse og forlaenget virkning
FR2622798B1 (fr) Forme d'apport dose et dispositif osmotique d'administration d'un medicament pour le traitement de maladies cardio-vasculaires
FI940787L (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
DK668787D0 (da) Flydende doseringsform til oral indgift af farmaceutisk virksomt stof
DK0490991T3 (da) Doseringsform til oral administration af hypoglykæmisk glipizid
FI894361A7 (fi) Injektori lääkerakeiden ihonalaiseksi annostelemiseksi
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
DK0768867T3 (da) Doseringsform til indgivelse af lægemiddel i væskeformig formulering
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
NO873273L (no) Flergranultablett for avgivelse av en aktiv bestanddel over tid.
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
ATE59550T1 (de) Chlorpheniramine therapie.
DK0538335T3 (da) Doseringsform til administration af et lægemiddel til at bevirke circadisk terapi
DK467586D0 (da) Medicindoseringsapparat for afgivelse af forstaevet medicin til inhaleringsluft
BR9808876A (pt) Sistema de liberação de medicamento
NO873805L (no) Medisinsk doseringsanordning for uttoemning av forstoevet medikament for inhaleringsluft.
GR1001447B (el) Φαρμακευτικά προιόντα για την χορήγηση καλτσιτονίνης ενδορινικώς.
DK0863729T3 (da) Implanterbar controlled release-anordning til administration af lægemidler direkte til en indre del af kroppen
DK466587D0 (da) Medicinsk doseringsindretning til afgivelse af forstoevet medikament ved inhalering af luft
ES268408Y (es) Dispositivo vaporizador de esencias de plantas medicinales con efectos terapeuticos.

Legal Events

Date Code Title Description
PUP Patent expired
PUP Patent expired